US118991A
(en)
*
|
|
1871-09-12 |
|
Improvement in tables and stands |
US1039867A
(en)
|
1910-03-25 |
1912-10-01 |
Reversible Gas Engine Company |
Ignition-timer.
|
US1039107A
(en)
|
1911-08-16 |
1912-09-24 |
Dean Electric Co |
Governing device.
|
GB1144905A
(en)
|
1965-03-25 |
1969-03-12 |
Fisons Pharmaceuticals Ltd |
Substituted bis-(2-carboxy-chromonyl-oxy) derivatives and preparation and pharmaceutical compositions thereof
|
US3777033A
(en)
|
1965-03-25 |
1973-12-04 |
Fisons Pharmaceuticals Ltd |
Bis-chromonyl pharmaceutical composi-tion and methods
|
US3686320A
(en)
|
1965-03-25 |
1972-08-22 |
Fisons Pharmaceuticals Ltd |
Bis-phenoxy compounds
|
US3686412A
(en)
|
1965-03-25 |
1972-08-22 |
Colin Fitzmaurice |
Compositions containing bis-chromonyl compounds for inhibiting antigen-antibody reactions
|
US3993073A
(en)
|
1969-04-01 |
1976-11-23 |
Alza Corporation |
Novel drug delivery device
|
US3598123A
(en)
|
1969-04-01 |
1971-08-10 |
Alza Corp |
Bandage for administering drugs
|
US3598122A
(en)
|
1969-04-01 |
1971-08-10 |
Alza Corp |
Bandage for administering drugs
|
US3720690A
(en)
|
1970-04-10 |
1973-03-13 |
Fisons Pharmaceuticals Ltd |
Pharmaceutically active bis-carboxychromone compounds
|
US3683320A
(en)
|
1970-05-08 |
1972-08-08 |
Bunker Ramo |
Coaxial cable connectors
|
CA958714A
(en)
|
1970-09-03 |
1974-12-03 |
Peter B. Johnson |
Bis-chromone derivatives
|
US3710795A
(en)
|
1970-09-29 |
1973-01-16 |
Alza Corp |
Drug-delivery device with stretched, rate-controlling membrane
|
US4069307A
(en)
|
1970-10-01 |
1978-01-17 |
Alza Corporation |
Drug-delivery device comprising certain polymeric materials for controlled release of drug
|
US3731683A
(en)
|
1971-06-04 |
1973-05-08 |
Alza Corp |
Bandage for the controlled metering of topical drugs to the skin
|
US3996934A
(en)
|
1971-08-09 |
1976-12-14 |
Alza Corporation |
Medical bandage
|
US3742951A
(en)
|
1971-08-09 |
1973-07-03 |
Alza Corp |
Bandage for controlled release of vasodilators
|
BE795384A
(fr)
|
1972-02-14 |
1973-08-13 |
Ici Ltd |
Pansements
|
US4152448A
(en)
|
1972-02-15 |
1979-05-01 |
Fisons Limited |
Method and composition for the treatment of a condition of the gastro intestinal tract
|
US3921636A
(en)
|
1973-01-15 |
1975-11-25 |
Alza Corp |
Novel drug delivery device
|
HK38179A
(en)
|
1973-12-19 |
1979-06-22 |
Fisons Ltd |
Topical compositions
|
US3993072A
(en)
|
1974-08-28 |
1976-11-23 |
Alza Corporation |
Microporous drug delivery device
|
US4151273A
(en)
|
1974-10-31 |
1979-04-24 |
The Regents Of The University Of California |
Increasing the absorption rate of insoluble drugs
|
US3972995A
(en)
|
1975-04-14 |
1976-08-03 |
American Home Products Corporation |
Dosage form
|
US4067992A
(en)
|
1975-09-10 |
1978-01-10 |
Fisons Limited |
Method of treating a psychiatric condition
|
US4077407A
(en)
|
1975-11-24 |
1978-03-07 |
Alza Corporation |
Osmotic devices having composite walls
|
US4031894A
(en)
|
1975-12-08 |
1977-06-28 |
Alza Corporation |
Bandage for transdermally administering scopolamine to prevent nausea
|
US4060084A
(en)
|
1976-09-07 |
1977-11-29 |
Alza Corporation |
Method and therapeutic system for providing chemotherapy transdermally
|
US4201211A
(en)
|
1977-07-12 |
1980-05-06 |
Alza Corporation |
Therapeutic system for administering clonidine transdermally
|
US4189571A
(en)
|
1978-02-07 |
1980-02-19 |
Fisons Limited |
Esters of cromoglycates
|
JPS5562012A
(en)
|
1978-11-06 |
1980-05-10 |
Teijin Ltd |
Slow-releasing preparation
|
US4230105A
(en)
|
1978-11-13 |
1980-10-28 |
Merck & Co., Inc. |
Transdermal delivery of drugs
|
US4229447A
(en)
|
1979-06-04 |
1980-10-21 |
American Home Products Corporation |
Intraoral methods of using benzodiazepines
|
US4268519A
(en)
|
1979-06-05 |
1981-05-19 |
Fisons Limited |
Method of treating otitis media
|
CA1146866A
(en)
|
1979-07-05 |
1983-05-24 |
Yamanouchi Pharmaceutical Co. Ltd. |
Process for the production of sustained release pharmaceutical composition of solid medical material
|
US4291015A
(en)
|
1979-08-14 |
1981-09-22 |
Key Pharmaceuticals, Inc. |
Polymeric diffusion matrix containing a vasodilator
|
FR2505798B1
(fr)
|
1981-05-14 |
1986-07-25 |
Pari Symac |
Perfectionnement aux dispositifs comportant un ressort helicoidal utilise comme organe de transfert, d'extraction, de dosage ou de melange
|
DE3365744D1
(en)
|
1982-01-22 |
1986-10-09 |
Fisons Plc |
Liposome and sodium cromoglycate compositions, and methods for their preparation
|
US4476116A
(en)
|
1982-12-10 |
1984-10-09 |
Syntex (U.S.A.) Inc. |
Polypeptides/chelating agent nasal compositions having enhanced peptide absorption
|
US5116817A
(en)
|
1982-12-10 |
1992-05-26 |
Syntex (U.S.A.) Inc. |
LHRH preparations for intranasal administration
|
US4683135A
(en)
|
1983-07-27 |
1987-07-28 |
Yeda Research And Development Co., Ltd. |
DSCG binding protein and process for preparing same
|
US4996296A
(en)
|
1983-07-27 |
1991-02-26 |
Yeda Research & Development Co., Ltd. |
Cromolyn binding protein in highly purifed form, and methods for the isolation thereof
|
GB8322178D0
(en)
|
1983-08-17 |
1983-09-21 |
Sterwin Ag |
Preparing aerosol compositions
|
US4634699A
(en)
|
1983-11-30 |
1987-01-06 |
Burroughs Wellcome Co. |
Branched chain phenothiazine
|
GB8332450D0
(en)
|
1983-12-06 |
1984-01-11 |
Fisons Plc |
Method of treatment
|
US4596795A
(en)
|
1984-04-25 |
1986-06-24 |
The United States Of America As Represented By The Secretary, Dept. Of Health & Human Services |
Administration of sex hormones in the form of hydrophilic cyclodextrin derivatives
|
GB2167300B
(en)
|
1984-11-23 |
1988-11-23 |
Fisons Plc |
Formulations
|
JPH0662601B2
(ja)
|
1985-08-16 |
1994-08-17 |
京都薬品工業株式会社 |
クロモグリク酸誘導体および抗アレルギ−剤
|
US4923892A
(en)
|
1985-08-17 |
1990-05-08 |
Burroughs Wellcome Co. |
Tricyclic aromatic compounds
|
GB8520662D0
(en)
|
1985-08-17 |
1985-09-25 |
Wellcome Found |
Tricyclic aromatic compounds
|
US4755386A
(en)
|
1986-01-22 |
1988-07-05 |
Schering Corporation |
Buccal formulation
|
US5231170A
(en)
|
1986-08-27 |
1993-07-27 |
Paul Averback |
Antibodies to dense microspheres
|
US5312325A
(en)
|
1987-05-28 |
1994-05-17 |
Drug Delivery Systems Inc |
Pulsating transdermal drug delivery system
|
DE3879811T2
(de)
|
1987-08-25 |
1993-10-07 |
Kuebler Gmbh Dr |
Pharmazeutische Zusammensetzung und ihre Verwendung.
|
US4906476A
(en)
*
|
1988-12-14 |
1990-03-06 |
Liposome Technology, Inc. |
Novel liposome composition for sustained release of steroidal drugs in lungs
|
EP0413583A3
(en)
|
1989-08-18 |
1991-07-17 |
Dey Laboratories; Inc. |
Clear, stable cromolyn formulation
|
US5739136A
(en)
|
1989-10-17 |
1998-04-14 |
Ellinwood, Jr.; Everett H. |
Intraoral dosing method of administering medicaments
|
US5280784A
(en)
|
1990-09-19 |
1994-01-25 |
Paul Ritzau Pari-Werk Gmbh |
Device in particular and inhalating device for treating the lung and the respiratory tracts
|
US5753208A
(en)
|
1990-11-09 |
1998-05-19 |
Egis Gyogyszergyar |
Antiasthmatic aerosol preparation of sodium cromoglycate
|
US5633009A
(en)
|
1990-11-28 |
1997-05-27 |
Sano Corporation |
Transdermal administration of azapirones
|
DK1516639T4
(da)
|
1990-12-05 |
2015-06-29 |
Gen Hospital Corp |
Anvendelse af NO til behandling af vedvarende pulmonal hypertension hos nyfødte
|
DE59107894D1
(de)
|
1991-03-21 |
1996-07-11 |
Ritzau Pari Werk Gmbh Paul |
Vernebler insbesondere zur Anwendung in Geräten für die Inhalationstherapie
|
AU1537292A
(en)
|
1991-04-16 |
1992-11-17 |
Nippon Shinyaku Co. Ltd. |
Method of manufacturing solid dispersion
|
US6123924A
(en)
|
1991-09-25 |
2000-09-26 |
Fisons Plc |
Pressurized aerosol inhalation compositions
|
EP0540775B1
(de)
|
1991-11-07 |
1997-07-23 |
PAUL RITZAU PARI-WERK GmbH |
Vernebler insbesondere zur Anwendung in Geräten für die Inhalationstherapie
|
ATE121971T1
(de)
|
1991-11-07 |
1995-05-15 |
Ritzau Pari Werk Gmbh Paul |
Flüssigkeitszerstäubervorrichtung.
|
US5618842A
(en)
|
1991-12-31 |
1997-04-08 |
Lifegroup S.P.A. |
N-acyl derivatives of aminoalcohols with polycarboxylic acids able to modulate mast cells in inflammatory processes having neuroimmunogenic origin
|
US5340591A
(en)
|
1992-01-24 |
1994-08-23 |
Fujisawa Pharmaceutical Co., Ltd. |
Method of producing a solid dispersion of the sparingly water-soluble drug, nilvadipine
|
US5281420A
(en)
|
1992-05-19 |
1994-01-25 |
The Procter & Gamble Company |
Solid dispersion compositions of tebufelone
|
GB9214390D0
(en)
|
1992-07-07 |
1992-08-19 |
Fisons Plc |
Formulations
|
AU4198793A
(en)
|
1992-07-24 |
1994-01-27 |
Takeda Chemical Industries Ltd. |
Microparticle preparation and production thereof
|
DE4225928A1
(de)
|
1992-08-05 |
1994-02-10 |
Ritzau Pari Werk Gmbh Paul |
Zerstäubervorrichtung mit Heizeinrichtung
|
US5700485A
(en)
|
1992-09-10 |
1997-12-23 |
Children's Medical Center Corporation |
Prolonged nerve blockade by the combination of local anesthetic and glucocorticoid
|
DE4310575C1
(de)
|
1993-03-31 |
1994-09-15 |
Ritzau Pari Werk Gmbh Paul |
Vorrichtung zum Erzeugen von Aerosolpulsen
|
GB9317752D0
(en)
|
1993-08-26 |
1993-10-13 |
Fisons Plc |
New pharmaceutical use
|
DE59308788D1
(de)
|
1993-12-17 |
1998-08-20 |
Pari Gmbh |
Zerstäuberdüse
|
US5508451A
(en)
|
1994-07-07 |
1996-04-16 |
Hoechst Celanese Corporation |
Process for the preparation of dialkali metal cromoglycates
|
US5665378A
(en)
|
1994-09-30 |
1997-09-09 |
Davis; Roosevelt |
Transdermal therapeutic formulation
|
US6000394A
(en)
|
1994-10-26 |
1999-12-14 |
Paul Rizau Pari-Werk Gmbh |
Generation of an aerosol of an exact dose
|
US5552436A
(en)
|
1995-04-03 |
1996-09-03 |
Ascent Pharmaceuticals, Inc. |
Process for treating hemangioma
|
US5576346A
(en)
|
1995-04-03 |
1996-11-19 |
Ascent Pharmaceuticals, Inc. |
Process for treating uremic pruritus
|
GB9507768D0
(en)
|
1995-04-13 |
1995-05-31 |
Glaxo Group Ltd |
Method of apparatus
|
DE19520622C2
(de)
|
1995-06-06 |
2003-05-15 |
Pari Gmbh |
Vorrichtung zum Vernebeln von Fluiden
|
SE9502244D0
(sv)
|
1995-06-20 |
1995-06-20 |
Bioglan Ab |
A composition and a process for the preparation thereof
|
CA2241515A1
(en)
|
1995-12-27 |
1997-07-10 |
Junko Shima |
Aqueous composition comprising cromoglycic acid
|
DE19602628C2
(de)
|
1996-01-25 |
2000-06-29 |
Pari Gmbh |
Vernebler
|
US6923983B2
(en)
|
1996-02-19 |
2005-08-02 |
Acrux Dds Pty Ltd |
Transdermal delivery of hormones
|
US6929801B2
(en)
|
1996-02-19 |
2005-08-16 |
Acrux Dds Pty Ltd |
Transdermal delivery of antiparkinson agents
|
US5824669A
(en)
|
1996-03-22 |
1998-10-20 |
Nitromed, Inc. |
Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders
|
US6225327B1
(en)
|
1996-04-18 |
2001-05-01 |
Alcon Laboratories, Inc. |
Compounds which inhibit human conjunctival mast cell degranulation for treating ocular allergic-type complications
|
ATE287257T1
(de)
|
1997-01-16 |
2005-02-15 |
Massachusetts Inst Technology |
Zubereitung von partikelhaltigen arzneimitteln zur inhalation
|
US6126919A
(en)
|
1997-02-07 |
2000-10-03 |
3M Innovative Properties Company |
Biocompatible compounds for pharmaceutical drug delivery systems
|
US6207684B1
(en)
|
1997-06-09 |
2001-03-27 |
Bridge Pharma, Inc. |
Compounds with combined antihistaminic and mast cell stabilizing activities, intended for ophthalmic use
|
US6391452B1
(en)
|
1997-07-18 |
2002-05-21 |
Bayer Corporation |
Compositions for nasal drug delivery, methods of making same, and methods of removing residual solvent from pharmaceutical preparations
|
DE19734022C2
(de)
|
1997-08-06 |
2000-06-21 |
Pari Gmbh |
Inhalationstherapiegerät mit einem Ventil zur Begrenzung des Inspirationsflusses
|
US5952353A
(en)
|
1997-09-19 |
1999-09-14 |
Auburn University |
Treating/preventing heart failure via inhibition of mast cell degranulation
|
ATE239447T1
(de)
|
1997-09-29 |
2003-05-15 |
Inhale Therapeutic Syst |
In verneblern verwendbare, stabilisierte zubereitungen
|
US6433040B1
(en)
|
1997-09-29 |
2002-08-13 |
Inhale Therapeutic Systems, Inc. |
Stabilized bioactive preparations and methods of use
|
US6365180B1
(en)
|
1998-01-20 |
2002-04-02 |
Glenn A. Meyer |
Oral liquid compositions
|
US5869090A
(en)
|
1998-01-20 |
1999-02-09 |
Rosenbaum; Jerry |
Transdermal delivery of dehydroepiandrosterone
|
US6323219B1
(en)
|
1998-04-02 |
2001-11-27 |
Ortho-Mcneil Pharmaceutical, Inc. |
Methods for treating immunomediated inflammatory disorders
|
GB9807232D0
(en)
|
1998-04-03 |
1998-06-03 |
Univ Cardiff |
Aerosol composition
|
GB9810949D0
(en)
|
1998-05-22 |
1998-07-22 |
Hewlett Healthcare Limited |
Formulation
|
DE19827228C2
(de)
|
1998-06-18 |
2000-07-13 |
Pari Gmbh |
Flüssigkeitszerstäubervorrichtung
|
US6946144B1
(en)
|
1998-07-08 |
2005-09-20 |
Oryxe |
Transdermal delivery system
|
NZ509328A
(en)
|
1998-07-24 |
2002-11-26 |
Jago Res A |
Medicinal aerosol formulations
|
ATE234604T1
(de)
*
|
1998-08-04 |
2003-04-15 |
Jago Res Ag |
Medizinische aerosolformulierungen
|
HUP0103188A2
(hu)
|
1998-08-07 |
2001-12-28 |
Emisphere Technologies, Inc. |
Vegyületek és készítmények hatóanyagok célbajuttatására
|
US6138973A
(en)
|
1998-09-15 |
2000-10-31 |
Brunswick Corporation |
Adjustable seat pedestal
|
GB9824604D0
(en)
|
1998-11-11 |
1999-01-06 |
Hewlett Healthcare Limited |
Treatment of allergic conditions
|
US6660715B2
(en)
|
1998-11-19 |
2003-12-09 |
Massachusetts Institute Of Technology |
Nonaqueous solutions and suspensions of macromolecules for pulmonary delivery
|
US7074388B2
(en)
|
1998-12-10 |
2006-07-11 |
Kos Life Science, Inc. |
Water stabilized medicinal aerosol formulation
|
EP2258183A1
(en)
|
1998-12-22 |
2010-12-08 |
The University of North Carolina at Chapel Hill |
Compounds and uses for the treatment of airway diseases and for the delivery of airway drugs
|
EP1146860A4
(en)
|
1999-01-08 |
2002-07-03 |
Emisphere Tech Inc |
POLYMER DRUG DELIVERY SYSTEMS AND COMPOUNDS
|
ATE400252T1
(de)
|
1999-02-10 |
2008-07-15 |
Pfizer Prod Inc |
Pharmazeutische feste dispersionen
|
BR0010262A
(pt)
|
1999-05-03 |
2002-01-15 |
Battelle Memorial Institute |
Composição para formar um aerossol, processo de preparação e de aerossolização de uma composição, e, dispositivo gerador de aerossol
|
US20020061281A1
(en)
*
|
1999-07-06 |
2002-05-23 |
Osbakken Robert S. |
Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
|
US6586008B1
(en)
|
1999-08-25 |
2003-07-01 |
Advanced Inhalation Research, Inc. |
Use of simple amino acids to form porous particles during spray drying
|
US6749835B1
(en)
|
1999-08-25 |
2004-06-15 |
Advanced Inhalation Research, Inc. |
Formulation for spray-drying large porous particles
|
ATE285755T1
(de)
|
1999-08-25 |
2005-01-15 |
Advanced Inhalation Res Inc |
Grosse poröse partikel erhältlich durch sprühtrocknung und geeignet zur pulmonalen anwendung
|
US7129274B1
(en)
|
1999-11-05 |
2006-10-31 |
Emisphere Technologies Inc. |
Phenoxy carboxylic acid compounds and compositions for delivering active agents
|
DE19962110C2
(de)
|
1999-12-22 |
2003-06-12 |
Pari Gmbh |
Inhalationsvernebler mit einstückigem Ventilelement
|
US6596261B1
(en)
|
2000-01-25 |
2003-07-22 |
Aeropharm Technology Incorporated |
Method of administering a medicinal aerosol formulation
|
US20020009491A1
(en)
|
2000-02-14 |
2002-01-24 |
Rothbard Jonathan B. |
Compositions and methods for enhancing drug delivery across biological membranes and tissues
|
US7871598B1
(en)
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
US8257744B2
(en)
|
2000-07-07 |
2012-09-04 |
Laboratorios Farmacéuticos Rovi, S.A. |
Pharmaceutical forms for the release of active compounds
|
UA81743C2
(uk)
|
2000-08-07 |
2008-02-11 |
Центокор, Инк. |
МОНОКЛОНАЛЬНЕ АНТИТІЛО ЛЮДИНИ, ЩО СПЕЦИФІЧНО ЗВ'ЯЗУЄТЬСЯ З ФАКТОРОМ НЕКРОЗУ ПУХЛИН АЛЬФА (ФНПα), ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ, ЩО ЙОГО МІСТИТЬ, ТА СПОСІБ ЛІКУВАННЯ РЕВМАТОЇДНОГО АРТРИТУ
|
TWI334439B
(en)
|
2001-08-01 |
2010-12-11 |
Centocor Inc |
Anti-tnf antibodies, compositions, methods and uses
|
US9755314B2
(en)
|
2001-10-16 |
2017-09-05 |
Fractus S.A. |
Loaded antenna
|
US7291721B2
(en)
|
2001-11-14 |
2007-11-06 |
Centocor, Inc. |
Anti-IL-6 antibodies, compositions, methods and uses
|
EP1461031B1
(en)
|
2001-11-29 |
2016-06-29 |
Emisphere Technologies, Inc. |
Formulations for oral administration of cromolyn sodium
|
TWI329105B
(en)
|
2002-02-01 |
2010-08-21 |
Rigel Pharmaceuticals Inc |
2,4-pyrimidinediamine compounds and their uses
|
US6596284B1
(en)
|
2002-04-30 |
2003-07-22 |
Thomas E. Fleming |
Treating eczema with a combination of isotonic saline ocean® and nasal mast cell stabilizers
|
JP2008522583A
(ja)
|
2002-06-14 |
2008-07-03 |
セントカー・インコーポレーテツド |
修飾“s”抗体
|
WO2004003149A2
(en)
|
2002-06-27 |
2004-01-08 |
Centocor, Inc. |
Cngh0005 polypeptides, antibodies, compositions, methods and uses
|
EP1578930A4
(en)
|
2002-06-27 |
2008-07-02 |
Centocor Inc |
CNGH0004 POLYPEPTIDES, ANTIBODIES, COMPOSITIONS, METHODS AND USES
|
AU2003272450A1
(en)
|
2002-09-13 |
2004-04-30 |
C. Steven Smith |
Novel composition and method for treatment of upper respiratory conditions
|
US7550133B2
(en)
|
2002-11-26 |
2009-06-23 |
Alexza Pharmaceuticals, Inc. |
Respiratory drug condensation aerosols and methods of making and using them
|
SE0203687D0
(sv)
|
2002-12-13 |
2002-12-13 |
Ian Harwigsson Med Adagit Fa |
Pharmaceutical Porous Particles
|
WO2005028511A2
(en)
|
2003-03-28 |
2005-03-31 |
Centocor, Inc. |
Anti-amyloid antibodies, compositions, methods and uses
|
US7582297B2
(en)
|
2003-04-11 |
2009-09-01 |
Medimmune, Llc |
Methods of treating respiratory conditions
|
CN101052726A
(zh)
|
2003-05-09 |
2007-10-10 |
森托科尔公司 |
IL-23p40特异性免疫球蛋白衍生蛋白、组合物、方法和用途
|
EP1644416A4
(en)
|
2003-06-30 |
2007-08-29 |
Centocor Inc |
ANTI-TARGET AND GENETICALLY MODIFIED IMMUNOGLOBULIN-DERIVED PROTEINS, COMPOSITIONS, METHODS AND USES
|
US20050026880A1
(en)
|
2003-07-31 |
2005-02-03 |
Robinson Cynthia B. |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a cromone for treatment of asthma or chronic obstructive pulmonary disease
|
DE10347994A1
(de)
|
2003-10-15 |
2005-06-16 |
Pari GmbH Spezialisten für effektive Inhalation |
Wässrige Aerosol-Zubereitung
|
US20050209141A1
(en)
|
2003-10-17 |
2005-09-22 |
Silver Randi B |
Mast cell-derived renin
|
US20050232923A1
(en)
|
2003-11-05 |
2005-10-20 |
Li Yan |
Methods and compositions for treating MCP-1 related pathologies
|
US20060078558A1
(en)
|
2003-11-12 |
2006-04-13 |
Whitsett Jeffrey A |
Diagnosis, prognosis and treatment of pulmonary diseases
|
DE10355559A1
(de)
|
2003-11-21 |
2005-06-23 |
Orthogen Ag |
Transskin
|
US20050191246A1
(en)
|
2003-12-13 |
2005-09-01 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Powders comprising low molecular dextran and methods of producing those powders
|
US8088935B2
(en)
|
2003-12-23 |
2012-01-03 |
Ironwood Pharmaceuticals, Inc. |
Compounds and methods for the treatment of asthma
|
IL160936A0
(en)
|
2004-02-05 |
2004-08-31 |
Scott A Cordray |
Nasal spray and wash
|
EP1720573A4
(en)
|
2004-02-27 |
2008-04-02 |
Centocor Inc |
METHODS AND COMPOSITIONS FOR TREATING PATHOLOGIES ASSOCIATED WITH IL-13
|
AU2005249410A1
(en)
|
2004-05-14 |
2005-12-15 |
Emisphere Technologies, Inc. |
Aryl ketone compounds and compositions for delivering active agents
|
JP4468361B2
(ja)
|
2004-05-26 |
2010-05-26 |
株式会社リバース・プロテオミクス研究所 |
新規創薬ターゲットならびにこれに作用する医薬
|
WO2006029182A2
(en)
|
2004-09-07 |
2006-03-16 |
The La Jolla Institute For Molecular Medicine |
Use of mdl-100,907 for treatment of allergic and eosinophil mediated diseases
|
WO2006039470A2
(en)
|
2004-09-29 |
2006-04-13 |
Centocor, Inc. |
Anti- amyloid antibodies, compositions, methods and uses
|
JP2008546634A
(ja)
|
2005-03-16 |
2008-12-25 |
ハネウェル・インターナショナル・インコーポレーテッド |
医薬送達製剤、デバイス及び方法
|
WO2006105538A2
(en)
|
2005-03-31 |
2006-10-05 |
Centocor, Inc. |
Methods and compositions for treating il-21 related pathologies
|
EP1712220A1
(en)
|
2005-04-15 |
2006-10-18 |
PARI GmbH Spezialisten für effektive Inhalation |
Pharmaceutical aerosol composition
|
AU2012238334A1
(en)
|
2005-06-30 |
2012-11-01 |
Abbvie Inc. |
IL-12/p40 binding proteins
|
US7612181B2
(en)
|
2005-08-19 |
2009-11-03 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
GB0520794D0
(en)
|
2005-10-12 |
2005-11-23 |
Innovata Biomed Ltd |
Inhaler
|
US7566743B2
(en)
|
2005-11-18 |
2009-07-28 |
Mark Glazman |
System and method for medical treatment
|
EP1962869B1
(en)
|
2005-12-21 |
2013-03-20 |
SolAeroMed Inc. |
Treatment of respiratory diseases
|
EA035459B1
(ru)
|
2005-12-29 |
2020-06-19 |
Сентокор, Инк. |
Антитело против il-23p19
|
DE102006001113B3
(de)
|
2006-01-09 |
2007-06-28 |
Pari GmbH Spezialisten für effektive Inhalation |
Aerosoltherapievorrichtung
|
US8263645B2
(en)
*
|
2006-02-03 |
2012-09-11 |
Pari Pharma Gmbh |
Disodium cromoglycate compositions and methods for administering same
|
TR201807714T4
(tr)
|
2006-02-10 |
2018-06-21 |
Pari Pharma Gmbh |
İnhalasyon tedavisine yönelik nebülize antibiyotikler.
|
WO2007103970A2
(en)
|
2006-03-07 |
2007-09-13 |
Endacea, Inc. |
Compositions and methods for treating respiratory disorders
|
US20080035141A1
(en)
|
2006-06-16 |
2008-02-14 |
Warner W R |
Aerosolized therapy kit
|
EP2043687A4
(en)
|
2006-06-29 |
2010-03-17 |
Centocor Ortho Biotech Inc |
ANTI-AMYLOID ANTIBODIES, COMPOSITIONS, METHODS AND USES
|
US8445437B2
(en)
|
2006-07-27 |
2013-05-21 |
The Brigham And Women's Hospital, Inc. |
Treatment and prevention of cardiovascular disease using mast cell stabilizers
|
ES2902063T3
(es)
|
2006-09-08 |
2022-03-24 |
Abbvie Bahamas Ltd |
Proteínas de unión a interleucina-13
|
US20080078382A1
(en)
|
2006-09-20 |
2008-04-03 |
Lemahieu Edward |
Methods and Systems of Delivering Medication Via Inhalation
|
GB0621707D0
(en)
|
2006-10-31 |
2006-12-13 |
Univ London Pharmacy |
Formulations for delivery via pressurised metered dose inhalers
|
WO2008073627A2
(en)
|
2006-11-03 |
2008-06-19 |
Alba Therapeutics Corporation |
Method of diagnosing and treating asthma
|
US8414909B2
(en)
|
2006-11-20 |
2013-04-09 |
Lutonix, Inc. |
Drug releasing coatings for medical devices
|
US20080227704A1
(en)
|
2006-12-21 |
2008-09-18 |
Kamens Joanne S |
CXCL13 binding proteins
|
US20110046050A1
(en)
|
2007-02-08 |
2011-02-24 |
Emisphere Technologies, Inc. |
Phenylalkylcarboxylic acid delivery agents
|
US8252807B2
(en)
|
2007-03-02 |
2012-08-28 |
Board Of Regents, The University Of Texas System |
Methods of inhibiting the interaction between S100 and the receptor for advanced glycation end-products
|
US20080214491A1
(en)
|
2007-03-02 |
2008-09-04 |
Logsdon Craig D |
Methods of Inhibiting the Interaction Between S100 and the Receptor for Advanced Glycation End-Products
|
WO2008116165A2
(en)
|
2007-03-21 |
2008-09-25 |
Next Safety, Inc. |
Methods and systems of delivering medication via inhalation
|
US7897776B2
(en)
|
2007-04-23 |
2011-03-01 |
Salutria Pharmaceuticals Llc |
Sulfonamide containing compounds for treatment of inflammatory disorders
|
EP2030644A1
(en)
|
2007-08-31 |
2009-03-04 |
PARI Pharma GmbH |
Aerosols for sinunasal drug delivery
|
WO2009045291A2
(en)
|
2007-09-28 |
2009-04-09 |
The Brigham And Women's Hospital, Inc. |
Mast cell stabilizers in the treatment of obesity
|
AU2008312611A1
(en)
|
2007-10-15 |
2009-04-23 |
Centocor, Inc. |
Human anti-amyloid antibodies, compositions, methods and uses
|
DE102007052380A1
(de)
|
2007-10-31 |
2009-05-07 |
Bitop Ag |
Osmolythaltige Zubereitungen zur Anwendung bei trockenen Schleimhäuten
|
CN101909682B
(zh)
|
2007-11-06 |
2013-09-18 |
3M创新有限公司 |
药物吸入装置及其部件
|
JP2011507593A
(ja)
|
2007-12-20 |
2011-03-10 |
アストラゼネカ・アクチエボラーグ |
粉末854を脱凝集解体する装置ならびに方法
|
WO2009103067A2
(en)
|
2008-02-14 |
2009-08-20 |
The Children's Hospital Of Philadelphia |
Compositions and methods to treat asthma
|
WO2009131695A1
(en)
|
2008-04-25 |
2009-10-29 |
Nektar Therapeutics |
Oligomer-bis-chromonyl compound conjugates
|
US20100260668A1
(en)
|
2008-04-29 |
2010-10-14 |
Abbott Laboratories |
Dual Variable Domain Immunoglobulins and Uses Thereof
|
CA2722466A1
(en)
|
2008-04-29 |
2009-11-05 |
Tariq Ghayur |
Dual variable domain immunoglobulins and uses thereof
|
EP2297209A4
(en)
|
2008-06-03 |
2012-08-01 |
Abbott Lab |
IMMUNOGLOBULINS WITH TWO VARIABLE DOMAINS AND USES THEREOF
|
UY31861A
(es)
|
2008-06-03 |
2010-01-05 |
Abbott Lab |
Inmunoglobulina con dominio variable dual y usos de la misma
|
US10517839B2
(en)
|
2008-06-09 |
2019-12-31 |
Cornell University |
Mast cell inhibition in diseases of the retina and vitreous
|
WO2010006059A1
(en)
|
2008-07-08 |
2010-01-14 |
Abbott Laboratories |
Prostaglandin e2 binding proteins and uses thereof
|
WO2010006060A2
(en)
|
2008-07-08 |
2010-01-14 |
Abbott Laboratories |
Prostaglandin e2 dual variable domain immunoglobulins and uses thereof
|
US20100087455A1
(en)
|
2008-10-06 |
2010-04-08 |
Auspex Pharmaceuticals, Inc. |
Substituted xanthine compounds
|
US20110195924A1
(en)
|
2008-10-08 |
2011-08-11 |
Logsdon Craig D |
Methods of Inhibiting the Interaction Between S100P and the Receptor for Advanced Glycation End-Products
|
US20110224312A1
(en)
|
2008-11-17 |
2011-09-15 |
Wayne State University |
Engineering porous particles of water soluble therapeutics for pressurized metered-dose inhaler formulations
|
WO2010065547A1
(en)
|
2008-12-01 |
2010-06-10 |
Map Pharmaceuticals, Inc. |
Inhalation delivery methods and devices
|
US20100233079A1
(en)
|
2008-12-04 |
2010-09-16 |
Abbott Laboratories |
Dual Variable Domain Immunoglobulins and Uses Thereof
|
US9925282B2
(en)
|
2009-01-29 |
2018-03-27 |
The General Hospital Corporation |
Cromolyn derivatives and related methods of imaging and treatment
|
US8617517B2
(en)
|
2009-01-29 |
2013-12-31 |
The General Hospital Corporation |
Cromolyn derivatives and related methods of imaging and treatment
|
TW201031421A
(en)
|
2009-01-29 |
2010-09-01 |
Abbott Lab |
IL-1 binding proteins
|
BRPI1013688A8
(pt)
|
2009-03-05 |
2017-02-14 |
Abbott Lab |
Proteínas de ligação de il-17.
|
US8470805B2
(en)
|
2009-04-30 |
2013-06-25 |
Kaohsiung Medical University |
Processes for preparing piperazinium salts of KMUP and use thereof
|
AU2010242830C1
(en)
|
2009-05-01 |
2014-02-13 |
Abbvie Inc. |
Dual variable domain immunoglobulins and uses thereof
|
ES2457442T3
(es)
*
|
2009-05-08 |
2014-04-25 |
Pari Pharma Gmbh |
Formulaciones farmacéuticas concentradas estabilizadoras de los mastocitos
|
TW201109438A
(en)
|
2009-07-29 |
2011-03-16 |
Abbott Lab |
Dual variable domain immunoglobulins and uses thereof
|
NZ598929A
(en)
|
2009-09-01 |
2014-05-30 |
Abbvie Inc |
Dual variable domain immunoglobulins and uses thereof
|
MX2012004412A
(es)
|
2009-10-15 |
2012-05-08 |
Abbott Lab |
Proteinas de union a il-1.
|
TW201119676A
(en)
|
2009-10-15 |
2011-06-16 |
Abbott Lab |
Dual variable domain immunoglobulins and uses thereof
|
UY32979A
(es)
|
2009-10-28 |
2011-02-28 |
Abbott Lab |
Inmunoglobulinas con dominio variable dual y usos de las mismas
|
TR201000733A2
(tr)
|
2010-02-02 |
2011-08-22 |
Bi̇lgi̇ç Mahmut |
Flutikazon, tiotropyum ve sodyum kromoglikat içeren farmasötik bileşimler.
|
AU2011237679B2
(en)
|
2010-04-07 |
2014-11-06 |
Abbvie Inc. |
TNF-alpha binding proteins
|
AU2015200579A1
(en)
|
2010-04-07 |
2015-02-26 |
Abbvie Inc. |
TNF-alpha binding proteins
|
MY161302A
(en)
|
2010-05-14 |
2017-04-14 |
Abbvie Inc |
IL-1 binding proteins
|
AU2016222339B2
(en)
|
2010-05-14 |
2017-11-23 |
Abbvie Inc. |
IL-1 binding proteins
|
US8586044B2
(en)
|
2010-05-28 |
2013-11-19 |
Northwestern University |
Treatment of chronic pelvic pain syndrome
|
US9592220B2
(en)
|
2010-06-17 |
2017-03-14 |
Aradigm Corporation |
Diagnosis and treatment methods for entry of gastrointestinal contents into respiratory tract
|
RU2013104024A
(ru)
|
2010-07-21 |
2014-08-27 |
Астразенека Аб |
Ингалятор
|
AU2011293253B2
(en)
|
2010-08-26 |
2014-12-11 |
Abbvie Inc. |
Dual variable domain immunoglobulins and uses thereof
|
US20120076859A1
(en)
|
2010-09-23 |
2012-03-29 |
Activaero Gmbh |
Targeted Lung Delivery of Citrulline and/or Another Nitric Oxide Precursor and a Method for Treatment of Pulmonary Deficiency of Nitric Oxide in Cystic Fibrosis and Other Pulmonary Diseases
|
SG191712A1
(en)
|
2010-11-02 |
2013-08-30 |
Abbvie Inc |
Dual variable domain immunoglobulins and uses thereof
|
PE20141060A1
(es)
|
2010-12-21 |
2014-09-26 |
Abbvie Inc |
Inmunoglobulinas de dominio variable dual biespecificas de il-1 alfa y beta y su uso
|
US20120275996A1
(en)
|
2010-12-21 |
2012-11-01 |
Abbott Laboratories |
IL-1 Binding Proteins
|
UY33827A
(es)
|
2010-12-22 |
2012-07-31 |
Abbott Lab |
Proteínas de unión a media-inmunoglobulina y sus usos
|
EP2658538A2
(en)
*
|
2010-12-30 |
2013-11-06 |
M.D. Ziv Harish |
Preparations for topical prevention and/or treatment of oral allergic symptoms due to oral contact with fruits and/or vegetables
|
GB201110058D0
(en)
|
2011-06-15 |
2011-07-27 |
3M Innovative Properties Co |
Medicinal inhalation devices, valves and components thereof
|
SG11201400325WA
(en)
|
2011-09-06 |
2014-03-28 |
Verona Pharma Plc |
Treating cough and tussive attacks
|
US20130171059A1
(en)
|
2011-12-30 |
2013-07-04 |
Abbvie Inc. |
Dual variable domain immunoglobulins and uses thereof
|
AU2012362370A1
(en)
|
2011-12-30 |
2014-07-24 |
Abbvie Inc. |
Dual variable domain immunoglobulins against receptors
|
CN107929743B
(zh)
|
2012-01-18 |
2023-09-01 |
苏州泰飞尔医药有限公司 |
治疗肺部疾病的高穿透力前药组合物和医药组合物
|
GB2498746A
(en)
|
2012-01-26 |
2013-07-31 |
Innovata Biomed Ltd |
Inhaler which locks when empty
|
NZ722952A
(en)
|
2012-02-28 |
2018-12-21 |
Iceutica Holdings Inc |
Inhalable pharmaceutical compositions
|
US20150018396A1
(en)
|
2012-03-08 |
2015-01-15 |
President And Fellows Of Harvard College |
Prevention and treatment of respiratory infection with peroxisome proliferator activator receptor delta agonist
|
SG11201406142XA
(en)
|
2012-03-27 |
2014-10-30 |
Univ Duke |
Compositions and methods for the prevention and treatment of mast cell-induced vascular leakage
|
US10105500B2
(en)
|
2012-05-09 |
2018-10-23 |
Virginia Commonwealth University |
Dry powder inhaler (DPI) designs for producing aerosols with high fine particle fractions
|
BR112014029442A2
(pt)
|
2012-05-25 |
2017-06-27 |
Xlear Inc |
composições antimucosas à base de xilitol e métodos e composições relacionados
|
WO2014006631A1
(en)
|
2012-07-04 |
2014-01-09 |
Vijaya Rama Raju MUDUNURI |
Partitioned pool
|
US9427534B2
(en)
|
2012-07-05 |
2016-08-30 |
Clement Clarke International Ltd. |
Drug delivery inhaler devices
|
UY34905A
(es)
|
2012-07-12 |
2014-01-31 |
Abbvie Inc |
Proteínas de unión a il-1
|
CN110624107A
(zh)
|
2012-08-21 |
2019-12-31 |
赛诺菲生物技术公司 |
通过施用il-4r拮抗剂治疗或预防哮喘的方法
|
CN109846862A
(zh)
|
2012-10-25 |
2019-06-07 |
通用医疗公司 |
治疗阿尔茨海默病及相关疾病的组合疗法
|
EP2919762A4
(en)
|
2012-11-16 |
2016-07-20 |
Merck Sharp & Dohme |
PROCESS FOR THE PREPARATION OF AGGLOMERATES BY MEANS OF ACOUSTIC MIXING TECHNOLOGY
|
WO2014115098A1
(en)
|
2013-01-26 |
2014-07-31 |
Mahesh Kandula |
Compositions and methods for the treatment of neurological diseases and inflammation
|
WO2014144299A2
(en)
|
2013-03-15 |
2014-09-18 |
Abbvie Inc. |
DUAL SPECIFIC BINDING PROTEINS DIRECTED AGAINST TNFα
|
JP2016534976A
(ja)
|
2013-05-23 |
2016-11-10 |
アズセラピーズ インコーポレイテッド |
クロモリンを送達する方法
|
KR102196885B1
(ko)
|
2013-08-23 |
2020-12-30 |
애퍼런트 파마슈티컬스 인크. |
급성, 아급성 또는 만성 기침의 치료를 위한 디아미노피리미딘 p2x3 및 p2x2/3 수용체 조절제
|
CN110305095A
(zh)
|
2013-10-22 |
2019-10-08 |
综合医院公司 |
色甘酸衍生物以及成像和治疗的相关方法
|
US9492408B2
(en)
|
2013-10-24 |
2016-11-15 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Protection from chemical-induced acute lung injury
|
GB2522727B
(en)
|
2013-11-26 |
2017-01-25 |
Purity Health Pharma Ltd |
Pulmonary delivery devices
|
EP2883564A1
(en)
|
2013-12-16 |
2015-06-17 |
PARI Pharma GmbH |
Aerosol delivery device and method of operating the aerosol delivery device
|
US11485787B2
(en)
|
2014-02-05 |
2022-11-01 |
Dana-Farber Cancer Institute, Inc. |
Agents that modulate RGMb-neogenin-BMP signaling and methods of use thereof
|
PT3104854T
(pt)
*
|
2014-02-10 |
2020-06-26 |
Respivant Sciences Gmbh |
Estabilizadores de mastócitos para tratamento de doença pulmonar
|
WO2015120389A1
(en)
|
2014-02-10 |
2015-08-13 |
Patara Pharma, LLC |
Mast cell stabilizers treatment for systemic disorders
|
US20150273119A1
(en)
|
2014-03-26 |
2015-10-01 |
Snu R&Db Foundation |
Formulation comprising anti-scarring agents and biocompatible polymers for medical device coating
|
US20150306107A1
(en)
|
2014-04-24 |
2015-10-29 |
Jansfat Biotechnology Co., Ltd. |
SAA Derivative Compound Restores eNOS And Inhibits Oxidative Stress-Induced A Diseases In Hypoxia
|
WO2015161510A1
(en)
|
2014-04-25 |
2015-10-29 |
Jansfat Biotechnology Co., Ltd. |
Saa derivative compound restores enos and inhibits oxidative stress-induced diseases in hypoxia
|
US20150337315A1
(en)
|
2014-05-20 |
2015-11-26 |
Michael M. Grunstein |
Compositions and methods targeting signaling by the g protein beta-gamma subunit for the treatment of asthma
|
DE102014009164A1
(de)
|
2014-06-03 |
2015-12-03 |
Herbalist & Doc Gesundheitsgesellschaft Mbh |
Silikonölhaltige nasal anzuwendende Formulierungen
|
EP3152328A2
(en)
|
2014-06-05 |
2017-04-12 |
Transgenion-International Institute For Regenerative Translational Medicine Gmbh |
Methods of diagnosing chronic obstructive pulmonary disease (copd) using novel molecular biomarkers
|
WO2015185658A2
(en)
|
2014-06-05 |
2015-12-10 |
Medizinische Universität Wien |
Methods of diagnosing chronic obstructive pulmonary disease (copd) using novel molecular biomarkers
|
PL3152330T3
(pl)
|
2014-06-05 |
2021-09-13 |
Transgenion-International Institute For Regenerative Translational Medicine Gmbh |
SPOSOBY DIAGNOZOWANIA PRZEWLEKŁEJ OBTURACYJNEJ CHOROBY PŁUC (POChP) Z ZASTOSOWANIEM NOWYCH BIOMARKERÓW MOLEKULARNYCH
|
US20170218091A1
(en)
|
2014-07-03 |
2017-08-03 |
Abbvie Inc. |
Monovalent binding proteins
|
WO2016011254A1
(en)
|
2014-07-16 |
2016-01-21 |
Henry J. Legere Md, Pa |
Combinations of antihistamines and leukotriene antagonists and methods of use thereof
|
WO2016052953A1
(ko)
|
2014-09-30 |
2016-04-07 |
주식회사 엘지화학 |
(메트)아크릴레이트 화합물, 이로부터 유도된 반복단위를 포함하는 코폴리머 및 호모폴리머
|
US20170235918A1
(en)
|
2014-10-25 |
2017-08-17 |
Sumner Bluffs, Llc. |
Systems and methods for determining compliance and efficacy of a dosing regimen for a pharmaceutical agent
|
WO2017011729A1
(en)
|
2015-07-16 |
2017-01-19 |
Patara Pharma, LLC |
Combination therapies for the treatment of lung diseases
|
WO2017027402A1
(en)
|
2015-08-07 |
2017-02-16 |
Patara Pharma, LLC |
Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders
|
WO2017027387A1
(en)
|
2015-08-07 |
2017-02-16 |
Patara Pharma, LLC |
Methods for the treatment of mast cell related disorders with mast cell stabilizers
|
EP3349729A4
(en)
|
2015-09-14 |
2019-06-26 |
VGSK Technologies, Inc. |
STERILY STABILIZED MEDIUM FOR SUBCUTANEOUS, SUBLINGUAL AND ORAL THERAPEUTIC AGENTS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF A MAMMALIAN
|
EP3506893A4
(en)
|
2016-08-31 |
2020-01-22 |
Respivant Sciences GmbH |
CROMOLYNE COMPOSITIONS FOR THE TREATMENT OF CHRONIC COUGH DUE TO IDIOPATHIC PULMONARY FIBROSIS
|